Epigenetic approaches in the treatment of myelodysplastic syndromes: clinical utility of azacitidine

di McCormack, Steven E, Warlick, Erica D
Pubblicazione 2010

Successful Remission Rates and Survival after Lymphodepleting Chemotherapy for Relapsed Hematologic Malignancies Postallogeneic Hematopoietic Cell Transplantation

di Warlick, Erica D., DeFor, Todd, Blazar, Bruce R., Burns, Linda, Verneris, Michael R., Ustun, Celalettin, Weisdorf, Daniel J., Miller, Jeffrey S.
Pubblicazione 2011

Assessing acquired resistance to IDH1 inhibitor therapy by full-exon IDH1 sequencing and structural modeling

di Oltvai, Zoltán N., Harley, Susan E., Koes, David, Michel, Stephen, Warlick, Erica D., Nelson, Andrew C., Yohe, Sophia, Mroz, Pawel
Pubblicato in Cold Spring Harb Mol Case Stud (2021)

Differences in Community and Academic Practice Patterns for Newly Diagnosed Myelodysplastic Syndromes (MDS) Patients

di Pease, Daniel F., Ross, Julie A., Poynter, Jenny N., Nguyen, Phuong L., Hirsch, Betsy, Cioc, Adina, Roesler, Michelle A., Warlick, Erica D.
Pubblicato in Cancer Epidemiol (2015)

Predictive value of disease risk comorbidity index for overall survival after allogeneic hematopoietic transplantation

di Bejanyan, Nelli, Brunstein, Claudio G., Cao, Qing, Lazaryan, Aleksandr, Ustun, Celalettin, Warlick, Erica D., Arora, Mukta, Wagner, John E., Weisdorf, Daniel J.
Pubblicato in Blood Adv (2019)

Factors Predicting Early Mortality After New Diagnosis of Myelodysplastic Syndrome (MDS): A Population Based Study

di Jacobsen, Annie M., Poynter, Jenny N., Richardson, Michaela R., Nguyen, Phuong L., Hirsch, Betsy, Cioc, Adina, Roesler, Michelle A., Warlick, Erica D.
Pubblicato in Eur J Haematol (2019)

Reduced Intensity Hematopoietic-cell Transplantation in Older Patients with AML/MDS: Umbilical Cord Blood is a Feasible Option for Patients without HLA-matched Sibling Donors

di Majhail, Navneet S, Brunstein, Claudio G, Shanley, Ryan, Sandhu, Karamjeet, McClune, Brian, Oran, Betul, Warlick, Erica D, Wagner, John E, Weisdorf, Daniel J
Pubblicazione 2011

Factors Associated with Hematopoietic Cell Transplantation (HCT) Among Patients in a Population Based Study of Myelodysplastic Syndrome (MDS) in Minnesota

di Smith, Angela R., Warlick, Erica D., Roesler, Michelle A., Poynter, Jenny N., Richardson, Michaela, Nguyen, Phuong, Cioc, Adina, Hirsch, Betsy, Ross, Julie A.
Pubblicato in Ann Hematol (2015)

Monosomal karyotype at the time of diagnosis or transplantation predicts outcomes of Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome

di Ustun, Celalettin, Trottier, Bryan J., Sachs, Zohar, DeFor, Todd E., Shune, Leyla, Courville, Elizabeth, Holtan, Shernan G., Dolan, Michelle, Weisdorf, Daniel J., Warlick, Erica D.
Pubblicato in Biol Blood Marrow Transplant (2015)

Absence of early HHV-6 reactivation after cord blood allograft predicts powerful graft-versus-tumor effect

di Rashidi, Armin, Ebadi, Maryam, Said, Bassil, Cao, Qing, Shanley, Ryan, Curtsinger, Julie, Bejanyan, Nelli, Warlick, Erica D., Green, Jaime S., Brunstein, Claudio G., Miller, Jeffrey S., Weisdorf, Daniel J.
Pubblicato in Am J Hematol (2018)

Allogeneic hematopoietic cell transplant outcomes in acute myeloid leukemia: Similar outcomes regardless of donor type

di Warlick, Erica D., de Latour, Regis Peffault, Shanley, Ryan, Robin, Marie, Bejanyan, Nelli, Xhaard, Alienor, Brunstein, Claudio, de Fontbrune, Flore Sicre, Ustun, Celalettin, Weisdorf, Daniel J, Socie, Gerard
Pubblicato in Biol Blood Marrow Transplant (2014)

Umbilical cord blood transplantation is a suitable option for consolidation of acute myeloid leukemia with FLT3-ITD

di Eckfeldt, Craig E., Randall, Nicole, Shanley, Ryan M., Yohe, Sophia, Bejanyan, Nelli, Dolan, Michelle, Warlick, Erica D., Verneris, Michael R., Brunstein, Claudio G., Wagner, John E., Weisdorf, Daniel J., Ustun, Celalettin
Pubblicato in Haematologica (2016)

Phase 1 study of a bispecific ligand-directed toxin targeting CD22 and CD19 (DT2219) for refractory B-cell malignancies

di Bachanova, Veronika, Frankel, Arthur E., Cao, Qing, Lewis, Dixie, Grzywacz, Bartosz, Verneris, Michael R., Ustun, Celalettin, Lazaryan, Aleksandr, McClune, Brian, Warlick, Erica D., Kantarjian, Hagop, Weisdorf, Daniel J., Miller, Jeffrey S., Vallera, Daniel A.
Pubblicato in Clin Cancer Res (2015)

Personalized Fludarabine Dosing To Reduce Non-Relapse Mortality In Hematopoietic Stem Cell Transplant Recipients Receiving Reduced Intensity Conditioning

di Sanghavi, Kinjal, Wiseman, Anthony, Kirstein, Mark N., Cao, Qing, Brundage, Richard, Jensen, Kyle, Rogosheske, John, Kurtzweil, Andy, Long-Boyle, Janel, Wagner, John, Warlick, Erica D., Brunstein, Claudio G, Weisdorf, Daniel J., Jacobson, Pamala A.
Pubblicato in Transl Res (2016)

Myeloablative Allogeneic Bone Marrow Transplant Using T Cell Depleted Allografts Followed by Post-Transplant GM-CSF in High Risk Myelodysplastic Syndromes

di Warlick, Erica D., O'Donnell, Paul V., Borowitz, Michael, Grupka, Nichon, Decloe, Lauren, Garrett-Mayer, Elizabeth, Borrello, Ivan, Brodsky, Robert, Fuchs, Ephraim, Huff, Carol Ann, Luznik, Leo, Matsui, William, Ambinder, Richard, Jones, Richard J., Smith, B. Douglas
Pubblicazione 2008

First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings

di MacMillan, Margaret L., Hippen, Keli L., McKenna, David H., Kadidlo, Diane, Sumstad, Darin, DeFor, Todd E., Brunstein, Claudio G., Holtan, Shernan G., Miller, Jeffrey S., Warlick, Erica D., Weisdorf, Daniel J., Wagner, John E., Blazar, Bruce R.
Pubblicato in Blood Adv (2021)

Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics

di Keklik, Fatma, Alrawi, Ezzideen Barjes, Cao, Qing, Bejanyan, Nelli, Rashidi, Armin, Lazaryan, Aleksandr, Arndt, Patrick, Dincer, Erhan H., Bachanova, Veronika, Warlick, Erica D., MacMillan, Margaret L., Arora, Mukta, Miller, Jeffrey, Brunstein, Claudio G, Weisdorf, Daniel J., Ustun, Celalettin
Pubblicato in Haematologica (2018)

Hematopoietic Cell Transplant–Related Toxicities and Mortality in Frail Recipients

di Pamukcuoglu, Merve, Bhatia, Smita, Weisdorf, Daniel J., DeFor, Todd E., Ustun, Celalettin, Nayar, Manju, Holtan, Shernan G., Jurdi, Najla-El, Thyagarajan, Bharat, Brunstein, Claudio G., Bachanova, Veronika, Warlick, Erica D., Severseike, Ben, Te, Hok Sreng, Lund, Troy, Arora, Mukta
Pubblicato in Biol Blood Marrow Transplant (2019)

Matching at HLA-C improved the outcomes after double umbilical cord blood transplantation for recipients of 2–4/6 HLA-matched grafts

di Brunstein, Claudio G., Cutler, Corey S., DeFor, Todd E., Kim, Haesook, Bejanyan, Nelli, Garfall, Alfred, Verneris, Michael R., Chen, Yi-Bin, Warlick, Erica D., Spitzer, Thomas, Miller, Jeffrey S., Antin, Joseph H., Weisdorf, Daniel J., Soiffer, Robert, Wagner, John E., Ballen, Karen K.
Pubblicato in Biol Blood Marrow Transplant (2016)

Differentiation therapy in poor risk myeloid malignancies: Results of a dose finding study of the combination bryostatin-1 and GM-CSF

di Smith, B. Douglas, Jones, Richard J., Cho, Eunpi, Kowalski, Jeanne, Karp, Judith E., Gore, Steven D., Vala, Milada, Meade, Brooke, Baker, Sharyn D., Zhao, Ming, Piantadosi, Steven, Zhang, Zhe, Blumenthal, Gideon, Warlick, Erica D., Brodsky, Robert A., Murgo, Anthony, Rudek, Michelle A., Matsui, William H.
Pubblicazione 2010